Ionis Pharmaceuticals shares slide as eplontersen misses key heart disease endpoint
See why the CARDIO-TTRansform miss complicates eplontersen’s ATTR-CM path and tests gene silencing on top of stabilizer therapy.
Pharma & Biotech